Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors.

[1]  Ajay N. Jain,et al.  Hidden Markov models approach to the analysis of array CGH data , 2004 .

[2]  Bradley P. Coe,et al.  A tiling resolution DNA microarray with complete coverage of the human genome , 2004, Nature Genetics.

[3]  R. Tibshirani,et al.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.

[5]  Daniel Pinkel,et al.  Genomic microarrays in human genetic disease and cancer. , 2003, Human molecular genetics.

[6]  P. Nelson,et al.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.

[7]  Wing Hung Wong,et al.  Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma. , 2003, Cancer research.

[8]  K. Gish,et al.  Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. , 2003, Cancer research.

[9]  Ajay N. Jain,et al.  Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in Fallopian tube carcinoma , 2003, Oncogene.

[10]  K. Chin,et al.  End-sequence profiling: Sequence-based analysis of aberrant genomes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Read,et al.  The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis , 2003, Genes, chromosomes & cancer.

[12]  Wen-Lin Kuo,et al.  Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. , 2003, Cancer research.

[13]  J. Witte,et al.  Prostate cancer aggressiveness locus on chromosome segment 19q12–q13.1 identified by linkage and allelic imbalance studies , 2003, Genes, chromosomes & cancer.

[14]  Ajay N. Jain,et al.  High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. , 2003, The American journal of pathology.

[15]  D. Johnston,et al.  Genetic markers useful for distinguishing between organ‐confined and locally advanced prostate cancer , 2003, Genes, chromosomes & cancer.

[16]  Takeshi Suzuki,et al.  Genome-Based Identification of Cancer Genes by Proviral Tagging in Mouse Retrovirus-Induced T-Cell Lymphomas , 2003, Journal of Virology.

[17]  R. Chakrabarti,et al.  LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. , 2003, The Journal of biological chemistry.

[18]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[19]  L. Holmberg,et al.  Quality of life after radical prostatectomy or watchful waiting. , 2002, The New England journal of medicine.

[20]  T. Shuin,et al.  Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization. , 2002, Cancer genetics and cytogenetics.

[21]  E. Latulippe,et al.  Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. , 2002, Cancer research.

[22]  Ajay N. Jain,et al.  Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. , 2002, Cancer research.

[23]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[24]  A. Hui,et al.  Genome wide detection of oncogene amplifications in nasopharyngeal carcinoma by array based comparative genomic hybridization. , 2002, International journal of oncology.

[25]  E. Lander,et al.  Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.

[26]  Ajay N. Jain,et al.  Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. , 2002, Cancer research.

[27]  D. Bostwick,et al.  Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer † , 2002, Genes, chromosomes & cancer.

[28]  T. Furuya,et al.  Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma , 2002, Cancer.

[29]  Torben F. Ørntoft,et al.  Genome-wide Study of Gene Copy Numbers, Transcripts, and Protein Levels in Pairs of Non-invasive and Invasive Human Transitional Cell Carcinomas* , 2002, Molecular & Cellular Proteomics.

[30]  J. Witte,et al.  Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies. , 2002, Neoplasia.

[31]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Ajay N. Jain,et al.  Assembly of microarrays for genome-wide measurement of DNA copy number , 2001, Nature Genetics.

[33]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[34]  R. Uppaluri,et al.  Transcript map of the 8p23 putative tumor suppressor region. , 2001, Genomics.

[35]  Russ B. Altman,et al.  Missing value estimation methods for DNA microarrays , 2001, Bioinform..

[36]  M. Day,et al.  RB activation and repression of C-MYC transcription precede apoptosis of human prostate epithelial cells. , 2001, Urology.

[37]  Ho-Keung Ng,et al.  Detection of Multiple Gene Amplifications in Glioblastoma Multiforme Using Array-Based Comparative Genomic Hybridization , 2001, Laboratory Investigation.

[38]  H. Moch,et al.  Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization * , 2001, The Prostate.

[39]  D Pinkel,et al.  High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. , 2001, Human molecular genetics.

[40]  H. Tanke,et al.  Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features. , 2001, The American journal of pathology.

[41]  大場 一生.  Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer , 2001 .

[42]  J. Dey,et al.  8pter-p23 deletion is associated with racial differences in prostate cancer outcome. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  D V Conti,et al.  Genomewide scan for prostate cancer-aggressiveness loci. , 2000, American journal of human genetics.

[44]  H. Tanke,et al.  Identification of Genetic Markers for Prostatic Cancer Progression , 2000, Laboratory Investigation.

[45]  M. Augustus,et al.  Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer. , 2000, The Journal of urology.

[46]  K. Pienta,et al.  Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  G. Bubley,et al.  Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor. , 1999, The American journal of pathology.

[48]  R. Cardiff,et al.  Roles for Nkx3.1 in prostate development and cancer. , 1999, Genes & development.

[49]  A. Renshaw,et al.  Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[51]  M. Poutanen,et al.  Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. , 1997, Cancer research.

[52]  R. T. Curtis,et al.  A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. , 1997, Genomics.

[53]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[54]  H. Levin,et al.  Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. , 1996, Urology.

[55]  P. Carroll,et al.  Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. , 1996, Cancer research.

[56]  D. Bostwick,et al.  Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. , 1995, Cancer research.

[57]  E. Schuuring,et al.  Amplified region of chromosome band 11q13 in breast and squamous cell carcinomas encompasses three CpG islands telomeric of FGF3, including the expressed gene EMS1 , 1993, Genes, chromosomes & cancer.

[58]  Y. Chaubey.  Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .

[59]  D. Gleason,et al.  Histologic grading of prostate cancer: a perspective. , 1992, Human pathology.

[60]  E. Schuuring,et al.  D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. , 1991, Oncogene.

[61]  G. Peters,et al.  Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. , 1990, European journal of cancer.

[62]  Lawrence R. Rabiner,et al.  A tutorial on hidden Markov models and selected applications in speech recognition , 1989, Proc. IEEE.

[63]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[64]  G. Schwarz.  Estimating the Dimension of a Model , 1978 .